CYCCyclopharm Limited

CYC Stock Price, Valuation & Chart | Cyclopharm Limited

Compare

$0.510-0.01 (-0.98%)

At close · 02 Sept 2026, 06:10 am

Sector: Healthcare Industry: Medical - Devices CYC intrinsic value CYC calculated fair value vs price Website

Overview Financials Dividends Ratios

CYC Historical price chart

CYC Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization63.50M

PE Ratio-3.23

EPS-0.16

Trading Volume30.99K

Today's High/Low0.54/0.51

Dividend Yield0.00

52 Week High/Low1.29/0.45

Shares Outstanding125.73M

CYC Financial Statement

CYC Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 1 analyst giving stock ratings to CYC in the past 3 months.

CYC Analysis & performance metrics

CYC Company profile

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas…

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the…

CYC Management team

Name

Position

Sui Ling Cheah

Financial Controller

Lynn McLauchlin

General Manager of Canada

James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO

Chief Executive Officer, MD, Company Secretary & Director

Mathew FaragCOO

Chief Operating Officer

Gary T. Somerville

Quality & Regulatory Manager

Niamh McAree

Head of Quality and Regulatory

Chris Quinn

Head of Service

Sally-Ann Cornelius

Head of Sales

Name

Position

Sui Ling Cheah

Financial Controller

Lynn McLauchlin

General Manager of Canada

James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO

Chief Executive Officer, MD, Company Secretary & Director

Mathew FaragCOO

Chief Operating Officer

Gary T. Somerville

Quality & Regulatory Manager

Niamh McAree

Head of Quality and Regulatory

Chris Quinn

Head of Service

Sally-Ann Cornelius

Head of Sales

Management Team

Sui Ling Cheah

Financial Controller

Lynn McLauchlin

General Manager of Canada

James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO

Chief Executive Officer, MD, Company Secretary & Director

Mathew FaragCOO

Chief Operating Officer

Gary T. Somerville

Quality & Regulatory Manager

Niamh McAree

Head of Quality and Regulatory

Chris Quinn

Head of Service

Sally-Ann Cornelius

Head of Sales

Management

Sui Ling Cheah

Financial Controller

Lynn McLauchlin

General Manager of Canada

James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO

Chief Executive Officer, MD, Company Secretary & Director

Mathew FaragCOO

Chief Operating Officer

Gary T. Somerville

Quality & Regulatory Manager

Niamh McAree

Head of Quality and Regulatory

Chris Quinn

Head of Service

Sally-Ann Cornelius

Head of Sales

Total 8 executives

CYC Frequently asked questions

What is Cyclopharm Limited (CYC) Stock Price?

Current stock price of Cyclopharm Limited (CYC) stock is $0.510. The stock price is -0.98% lower in the session. The intraday range can be seen from this page. Volume of Cyclopharm Limited (CYC) stock is 30.99K.

Last updated at 02 Sept 2026, 06:10 am.

Why is the Cyclopharm Limited (CYC) stock price going up or down today?

The stock price of Cyclopharm Limited (CYC) can change with earnings, company news, and overall market sentiment. Cyclopharm Limited operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cyclopharm Limited stock expensive at its current price?

Whether Cyclopharm Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CYC on this page is -3.23. EPS on this page is -0.16. Compare those figures with peers and growth expectations before deciding if the current Cyclopharm Limited price is justified.

How has the stock price of Cyclopharm Limited (CYC) performed historically?

Historical performance for Cyclopharm Limited (CYC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CYC reacted to past earnings and market events.

Should I buy Cyclopharm Limited (CYC) stock, at this price?

Buying Cyclopharm Limited (CYC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.